Quick Answer
FENNEC PHARMACEUTICALS INC. reported Gross Profit of $19.99 million for fiscal year 2023.
FENNEC PHARMACEUTICALS INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2023 | $19.99M | +1279.8% |
| 2022 | $1.45M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $6.18M | — | +94.6% |
| June 30, 2023 | $3.18M | — | +100.8% |
| March 31, 2023 | $1.58M | — | — |
- FENNEC PHARMACEUTICALS INC. showed an increase of +1279.8% in Gross Profit compared to the prior fiscal year.
- Over the 2022–2023 period, FENNEC PHARMACEUTICALS INC.’s gross profit has grown by 1279.8% (from $1.45 million to $19.99 million).
- The most recent figure is from FENNEC PHARMACEUTICALS INC.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 29, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: